Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:RMD
NYSE:RMDMedical Equipment

Is It Too Late to Consider ResMed After Weight Loss Drug Concerns and DCF Outlook?

Wondering if ResMed at around $245 a share is still good value or if the easy money has already been made? Let us unpack what the current price actually implies about the company. Over the last year ResMed has delivered a 7.8% return, with the stock up 7.6% year to date but only 0.5% over the past month and down 2.2% in the last week. This pattern suggests investors are still calibrating their view of its long term growth and risks. Recent headlines have focused on ResMed’s role in the fast...
NasdaqGS:MASI
NasdaqGS:MASIMedical Equipment

Is Masimo Attractive After 20% Share Price Slide and Consumer Health Expansion Scrutiny?

Many investors are wondering if Masimo at around $135 a share is a bargain in disguise or a value trap. This stock has been on a lot of watchlists lately. Despite a strong long term track record in medical technology, the stock is down about 2.9% over the last week, 7.7% over the last month, and roughly 20.5% over the past year. This has reset expectations and risk perceptions for many shareholders. Recent headlines have focused on Masimo's ongoing push into non invasive monitoring...
TSX:BTE
TSX:BTEOil and Gas

Is It Too Late to Consider Baytex After Its Ranger Oil Deal and 548% Five Year Surge?

If you are wondering whether Baytex Energy is still good value after its run, you are not alone. This piece will walk through what the current price actually bakes in. Over the last year the stock is up 36.5%, with a 13.9% gain year to date on top of a large 5 year return of 548.5%. This naturally raises the question of how much upside might be left from here. Recent moves in Baytex have been shaped by shifting oil price expectations and ongoing integration work following its Ranger Oil...
NasdaqCM:VRRM
NasdaqCM:VRRMProfessional Services

December 2025's Stock Selections Estimated To Be Priced Below Fair Value

As the U.S. stock market rebounds with major indices like the Dow Jones and S&P 500 poised to break their recent losing streaks, investors are closely monitoring inflation trends that have come in lower than expected. In this environment of fluctuating economic indicators, identifying stocks that may be undervalued can offer potential opportunities for those looking to capitalize on discrepancies between current prices and perceived fair value.
NYSEAM:ZDGE
NYSEAM:ZDGEInteractive Media and Services

3 Promising Penny Stocks With Market Caps Over $30M

Major stock indexes in the United States recently experienced a boost, with inflation data coming in cooler than anticipated, leading to a positive shift in market sentiment. For investors willing to explore beyond well-known companies, penny stocks—often associated with smaller or newer firms—continue to offer intriguing opportunities. Despite their vintage label, these stocks can provide growth potential at lower price points when backed by strong financials and solid fundamentals.
SEHK:990
SEHK:990Trade Distributors

Deep Source Holdings (SEHK:990) Share Placement Prompts Fresh Look at Valuation and Growth Expectations

Deep Source Holdings (SEHK:990) has just lined up a placement of 515 million new shares at HK$0.69, a roughly 4% dilution that raises fresh equity while putting investor focus squarely on capital allocation. See our latest analysis for Deep Source Holdings. With the latest placement coming as the share price sits around HK$0.70, the strong year to date share price return of roughly 79% and hefty five year total shareholder return of about 488% suggest longer term momentum has been powerful,...
SEHK:1818
SEHK:1818Metals and Mining

Why Zhaojin Mining Industry (SEHK:1818) Is Up 9.4% After Offshore Deep-Sea Gold Breakthrough And What's Next

Zhaojin Mining recently reported that its subsidiary Ruihai Mining achieved a breakthrough in offshore deep-sea gold exploration and resource validation, uncovering high-quality concealed ore bodies with grades well above China’s average and overcoming long-standing technical bottlenecks. This advance not only enhances Zhaojin Mining’s resource reserve profile but also underscores how technology-led exploration can reshape its role in global gold supply. We’ll now look at how this offshore...
SEHK:1070
SEHK:1070Consumer Durables

Did TCL’s X-Intelligence 3.0 AI Push Just Shift TCL Electronics Holdings' (SEHK:1070) Investment Narrative?

At its 2025 TCL Global Technology Innovation Conference held earlier this year, TCL Electronics highlighted broad AI integration across its operations, unveiling the X-Intelligence 3.0 large language model, Inkjet-printed OLED display production, and a suite of AI-enabled consumer devices. A distinctive element of the event was TCL’s emphasis on pairing proprietary AI platforms with sustainability-focused hardware, underpinned by global R&D investment and intelligent factories. We’ll now...
SEHK:636
SEHK:636Logistics

Is KLN Logistics Group (SEHK:636) Undervalued After Its Recent Share Price Recovery?

KLN Logistics Group (SEHK:636) has quietly outperformed the broader market this year, with the share price edging higher and annual revenue and net income both growing around 3%, drawing fresh interest from value focused investors. See our latest analysis for KLN Logistics Group. Trading at HK$7.07, the stock has staged a modest near term recovery with a 1 month share price return of 2.02%, but its 3 year total shareholder return of negative 38.67% shows longer term momentum is still...
SEHK:2157
SEHK:2157Biotechs

Lepu Biopharma (SEHK:2157): Valuation Check After Upfront Licensing Milestone with Excalipoint

Lepu Biopharma (SEHK:2157) just ticked off a key milestone, receiving its initial upfront licensing payment from Excalipoint after meeting deal conditions, a concrete step toward monetizing its CTM012 and CTM013 cancer assets. See our latest analysis for Lepu Biopharma. Despite today’s softer mood, with a negative 1 day share price return, Lepu Biopharma’s share price has still logged a triple digit year to date gain, while the 1 year total shareholder return, though strong, lags that surge...
SGX:D01
SGX:D01Consumer Retailing

Assessing DFI Retail Group (SGX:D01)’s Valuation After Its New Profit Growth and Dividend Roadmap

DFI Retail Group Holdings (SGX:D01) has just laid out a new three year roadmap, pairing double digit underlying profit growth targets with a higher 70% dividend payout ratio. This combination directly shapes the stock’s appeal. See our latest analysis for DFI Retail Group Holdings. The new roadmap lands after a powerful re-rating, with a roughly 76% year to date share price return and a 1 year total shareholder return of about 109%, signalling that momentum is firmly rebuilding after years of...
LSE:TMI
LSE:TMIShipping

Discover UK Penny Stocks: Journeo And 2 Others To Watch

The UK market has recently faced challenges, with the FTSE 100 index experiencing a downturn due to weak trade data from China, highlighting global economic interdependencies. In such fluctuating conditions, investors often look for stocks that can offer growth potential at lower entry points. Penny stocks, though an older term, continue to represent opportunities in smaller or newer companies that might not be on every investor's radar but have the potential for significant returns when...